Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial
Jean‐Bernard Masson, Gilles O’Hara, Rodrigo Estévez‐Loureiro, Xavier Millán et al.
Citations
2 citations
Journal
Circulation
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
2.78
article
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial
Jean‐Bernard Masson, Gilles O’Hara, Rodrigo Estévez‐Loureiro, Xavier Millán, Pedro Luis Cepas Guillén, Ana Laffond, Xavier Freixa, Erwan Salaün, Jean‐Michel Paradis, Josep Rodés‐Cabau, Jean Champagne, Malek Kass, Omar Abdel‐Razek, Pablo Salinas, Pablo Vidal-Calés, Dabit Arzamendi, Ignacio Cruz‐González, Luis Nombela-Franco y, Marco Pavesi, Marino Labinaz, Benjamin Hibbert, Réda Ibrahim, Mélanie Côté
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
CirculationVol. 152(25)
Institutions
Mayo Clinic (US), University of Ottawa (CA), Montreal Heart Institute (CA), St. Boniface Hospital (CA), Hospital de Sant Pau (ES), University Hospital Complex Of Vigo (ES), Hospital Clínico San Carlos (ES), Centre hospitalier universitaire de Québec (CA), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES), Complejo Hospitalario de Salamanca (ES), Lung Institute (US), Hospital Clínic de Barcelona (ES), Mayo Clinic in Arizona (US), Instituto de Investigación Biomédica de Salamanca (ES), FC Barcelona (ES), Centre Hospitalier de l’Université de Montréal (CA), Mayo Clinic in Florida (US), Barcelona Macula Foundation (ES), Université Laval (CA), Ottawa Heart Institute (CA), Université de Saint-Boniface (CA)